BLOOMINGTON − Poise had become a staple of Purdue basketball. Now, two games in a row, adding to what has become a four-game losing streak, the pivotal trait for success is lacking. It was one ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Medical school advocates warn Trump ...
Highlighting deals by PE firms pursuing investments in marketing agencies focused on pharma and life sciences; insights on a ...
The U.S. Health and Human Services Department is weighing plans to drastically cut federal government funding for domestic ...
Ireland’s pharmaceutical sector saw a major surge in exports in January, bolstering the country’s trade surplus as businesses ...
OxyContin-maker Purdue Pharma, which is owned by the Sackler family, filed a new bankruptcy plan Tuesday that would give creditors at least $7.4 billion to compensate victims of the opioid crisis.
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...
After a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a ...
( WJET/WFXP) — Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle ...
Dr. Baumgartner joins Applied as an accomplished global drug development leader with over 35 years of experience in senior regulatory, clinical development, and medical affairs roles. He has held a ...
Purdue Pharma has filed a new bankruptcy plan to settle thousands of lawsuits over the toll of the opioid painkiller ...
By Dietrich Knauth NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback